Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients

Heart Rhythm

Volumn 5, Issue 11, 2008, Pages 1517-1522

  Hauser, Robert G ^a   Maron, Barry J ^a   Marine, Joseph E ^b   Lampert, Rachel ^c   Kadish, Alan H ^d   Winters, Stephen L ^e   Scher, David L ^f   Biria, Mazda ^g   Kalia, Amit ^e  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MORRISTOWN MEMORIAL HOSPITAL   (United States)

^f Pinnacle Health System   (United States)

^g UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

High voltage ICD leads; Hypertrophic cardiomyopathy; Implantable cardioverter defibrillator

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; DEFIBRILLATION; DEFIBRILLATOR; ELECTRIC POTENTIAL; ELECTRIC SHOCK; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SUDDEN DEATH; SURVIVAL; TREATMENT FAILURE; UNITED STATES;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 57149137652     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.08.021     Document Type: Article

References (27)

1. Wigle E.D., Rakowski H., Kimball B.P., et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92 (1995) 1680-1692
2. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society clinical consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42 (2003) 1687-1713
3. Maron B.J. Sudden death in young athletes. N Eng J Med 349 (2003) 1064-1075
4. Maron B.J., Shen W.-K., Link M.S., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Eng J Med 342 (2000) 365-373
5. Almquist A.K., Montgomery J.V., Haas T.S., et al. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm 2 (2005) 814-819
6. Maron B.J., Spirito P., Shen W.-K., et al. Implantable cardioverter-defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
7. Hauser R.G., Kallinen L.M., Almquist A.K., et al. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 4 (2007) 892-896
8. Maisel W.H. Transvenous implantable cardioverter-defibrillator leads: the weakest link. Circulation 115 (2007) 2461-2463
9. Maisel W.H. Semper Fidelis-Consumer protection for patients with implanted medical devices. N Eng J Med 358 (2008) 985-987
10. Kleemann T., Becker T., Doenges K., et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115 (2007) 2474-2480
11. Hauser R.G., Cannom D., Hayes D.L., et al. Long-term structural failure of coaxial polyurethane implantable cardioverter-defibrillator leads. Pacing Clin Electrophysiol 25 (2002) 879-882
12. Ellenbogen K.A., Wood M.A., Shepard R.K., et al. Detection and management of an implantable cardioverter defibrillator lead failure. J Am Coll Cardiol 41 (2003) 73-80
13. Dorwarth U., Frey B., Dugas M., et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 14 (2003) 38-43
14. Kitamura S., Satomi K., Kurita T., et al. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J 70 (2006) 273-277
15. Gelder R.N., Galvin J.M., Albert C.M., et al. Lead noise with active-fixation defibrillation lead. Pacing Clin Electrophysiol 23 (2000) 2113-2116
16. Medtronic product performance report 2008. 1st ed. http://www.medtronic.com/crm/performance/downloads/mdt-prod-performance-2008-1-en.pdf
17. Mesali A., Thomas O., Chauvin M., et al. Death due to an implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol 15 (2004) 953-956
18. Veltmann C., Borggrefe M., Schimpf R., et al. Fatal inappropriate shock. J Cardiovasc Electrophysiol 18 (2007) 326-328
19. Vollmann D., Luthje L., Vonhof S., et al. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart Rhythm 2 (2004) 307-309
20. Klein R.C., Raitt M.H., Wilkoff B.L., et al. Analysis of implantable cardioverter defibrillator therapy in the antiarrhythmics versus implantable defibrillator (AVID) trial. J Cardiovasc Electrophysiol 14 (2003) 940-948
21. Rosenqvist M., Beyer B., Block M., et al. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. Circulation 98 (1998) 663-670
22. Namerow P.B., Firth B.R., Heywood G.M., et al. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch trial. Pacing Clin Electrophysiol 22 (1999) 1305-1313
23. Irvine J., Dorian P., Baker B., et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 144 (2002) 282-289
24. Gehi A.K., Mehta D., and Gomes J.A. Evaluation and management of patients after implantable cardioverter-defibrillator shock. JAMA 296 (2006) 2839-2847
25. Friedman P.A., McClelland R.L., Bamlet W.R., et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 113 (2006) 2871-2879
26. Marin F., Gimeno J.R., Paya E., et al. Implantable cardioverter defibrillator and hypertrophic cardiomyopathy. Experience at three centers. Rev Esp Cardiol 59 (2006) 537-544
27. Kapa S., Curwin J.H., Coyne R.F., et al. Inappropriate defibrillator shocks from depolarization-repolarization mismatch in a patient with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 30 (2007) 1408-1411